Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Rossjohn

Showing results (461-470 of 534) with videos related to

Pageof 54
Sort By:
Nature Immunology|June 14, 2011
A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition propertiesAdam P Uldrich, Onisha Patel, Garth Cameron, et al.
Cell|March 25, 2017
A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor FamilyOscar A Aguilar, Richard Berry, Mir Munir A Rahim, et al.
Nature Immunology|May 14, 2013
Targeting of a natural killer cell receptor family by a viral immunoevasinRichard Berry, Natasha Ng, Philippa M Saunders, et al.
Cell Chemical Biology|March 27, 2018
Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor ImmunityDivya Chennamadhavuni, Noemi Alejandra Saavedra-Avila, Leandro J Carreño, et al.
Cell Chemical Biology|July 21, 2018
Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor ImmunityDivya Chennamadhavuni, Noemi Alejandra Saavedra-Avila, Leandro J Carreño, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2021
Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1dCatarina F Almeida, Dylan G M Smith, Tan-Yun Cheng, et al.
Immunity|May 26, 2009
Antigen ligation triggers a conformational change within the constant domain of the alphabeta T cell receptorTravis Beddoe, Zhenjun Chen, Craig S Clements, et al.
Nature|October 12, 2012
MR1 presents microbial vitamin B metabolites to MAIT cellsLars Kjer-Nielsen, Onisha Patel, Alexandra J Corbett, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2020
Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigensHamish E G McWilliam, Jeffrey Y W Mak, Wael Awad, et al.
Science (New York, N.Y.)|June 4, 2021
Canonical T cell receptor docking on peptide-MHC is essential for T cell signalingPirooz Zareie, Christopher Szeto, Carine Farenc, et al.
Pageof 54

Showing results (461-470 of 534) with videos related to

Sort By:
Pageof 54
Nature Immunology|June 14, 2011
A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition propertiesAdam P Uldrich, Onisha Patel, Garth Cameron, et al.
Cell|March 25, 2017
A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor FamilyOscar A Aguilar, Richard Berry, Mir Munir A Rahim, et al.
Nature Immunology|May 14, 2013
Targeting of a natural killer cell receptor family by a viral immunoevasinRichard Berry, Natasha Ng, Philippa M Saunders, et al.
Cell Chemical Biology|March 27, 2018
Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor ImmunityDivya Chennamadhavuni, Noemi Alejandra Saavedra-Avila, Leandro J Carreño, et al.
Cell Chemical Biology|July 21, 2018
Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor ImmunityDivya Chennamadhavuni, Noemi Alejandra Saavedra-Avila, Leandro J Carreño, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2021
Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1dCatarina F Almeida, Dylan G M Smith, Tan-Yun Cheng, et al.
Immunity|May 26, 2009
Antigen ligation triggers a conformational change within the constant domain of the alphabeta T cell receptorTravis Beddoe, Zhenjun Chen, Craig S Clements, et al.
Nature|October 12, 2012
MR1 presents microbial vitamin B metabolites to MAIT cellsLars Kjer-Nielsen, Onisha Patel, Alexandra J Corbett, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2020
Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigensHamish E G McWilliam, Jeffrey Y W Mak, Wael Awad, et al.
Science (New York, N.Y.)|June 4, 2021
Canonical T cell receptor docking on peptide-MHC is essential for T cell signalingPirooz Zareie, Christopher Szeto, Carine Farenc, et al.
Pageof 54